脑部放疗，上午比下午敏感许多！
) R( P$ B) Q& w1 i9 I1 ?7 \$ m# s) u% Y/ O$ z i2 @
3 {/ a) a8 J/ X1 U/ hCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
. F2 z& Z' q$ q5 T. L$ CGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?: l$ _( Y4 I5 V$ ^
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T./ G5 b, f5 i& b% `9 u6 I7 o8 o3 q' w
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.4 N/ C! S" c( E7 h5 ^ o8 _/ p
7 s9 @8 ?' B4 {$ D4 j+ b7 X
Abstract
1 S5 s) x: b) @BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.- a( G3 m A1 T- n( m$ n5 g9 N' S
- s9 y% o% [# b7 o* Y2 xMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
4 ?; }# j& F5 I5 P
" v# P9 Q" a9 m) BRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
8 o4 d8 ~7 u7 e: k' W
& R" J( m. R0 ]1 DCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.7 W- I6 T) v$ w5 e3 h1 H2 `
% N1 u( e) L) P9 ~ |
^, h0 \" x" r! \# A b
显身卡
